Back to Search
MATT CIESIELSKI DO
DO
Family Medicine Physician
NPI: 1861462327IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
5101013940(MI)
Education
UNIVERSITY OF NEW ENGLAND, COLLEGE OF OSTEO MEDICINE
Class of 1998
Research & Publications (20)
Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma.
PMID 18438666·Cancer Immunol Immunother·2008
7-preclinical
Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas.
PMID 16485128·Cancer Immunol Immunother·2006
7-preclinical
Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.
PMID 15340764·Cancer Immunol Immunother·2005
4-observational
Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting.
PMID 19152070·J Neurooncol·2009
7-preclinical
Radiosensitization of GL261 glioma cells by tetraiodothyroacetic acid (tetrac).
PMID 19597333·Cell Cycle·2009
7-preclinical
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.
PMID 19588228·J Neurooncol·2009
7-preclinical
MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.
PMID 19458603·J Cereb Blood Flow Metab·2009
7-preclinical
Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells.
PMID 18941255·J Immunol·2008
7-preclinical
Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
PMID 18245552·Clin Cancer Res·2008
7-preclinical
Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
PMID 17317838·Clin Cancer Res·2007
7-preclinical
Photophysical, electrochemical characteristics and cross-linking of STAT-3 protein by an efficient bifunctional agent for fluorescence image-guided photodynamic therapy.
PMID 18046480·Photochem Photobiol Sci·2007
7-preclinical
Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.
PMID 17597331·Cancer Immunol Immunother·2007
7-preclinical
EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?
PMID 18645600·Curr Genomics·2007
8-other
Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.
PMID 16778107·Clin Cancer Res·2006
7-preclinical
Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.
PMID 15671565·Clin Cancer Res·2005
7-preclinical
Assessment of intercomponent interaction in phenylene bridged dinuclear ruthenium(II) and osmium(II) polypyridyl complexes.
PMID 15558118·Dalton Trans·2004
8-other
2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro.
PMID 15312684·Cancer Lett·2004
7-preclinical
Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
PMID 15308179·Appl Radiat Isot·2004
7-preclinical
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
PMID 15308165·Appl Radiat Isot·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3300 W CENTRE AVE
PORTAGE, MI 49024 - Phone
- (269) 324-8950
Quick Facts
- NPI
- 1861462327
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile